Processa Pharmaceuticals, Inc.
PCSA$160M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaVERO BEACH10 employees
Drugs in Pipeline
4
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Sep 15, 2026
26wMarket Overview
Stock performance and key metrics
PCSA News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
PCS12852
Gastroparesis
PCS6422 and capecitabine
Breast Cancer
RX-3117
Metastatic Pancreatic Cancer
PCS499
Necrobiosis Lipoidica
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
PCS12852 | Phase 2 | Gastroparesis | - | - |
PCS6422 and capecitabine | Phase 2 | Breast Cancer | - | - |
RX-3117 | Phase 2 | Metastatic Pancreatic Cancer | - | - |
PCS499 | Phase 2 | Necrobiosis Lipoidica | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply